secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001213900-25-039733
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio schedules Q1 2025 earnings call for May 8; no results released yet
-----------------------------------------------------------------------------

- Press release dated May 5, 2025 announces conference call on May 8, 2025 at 4:30 p.m. ET.
- Call will discuss Q1 2025 financial results and provide a corporate update.
- Dial-in: 1-800-267-6316 (US) or +1-203-518-9783 (international); Conference ID: INMUNE.
- Webcast and replay available; transcript expected within 24 hours.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025039733/0001213900-25-039733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025039733/ea0240883-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-039733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer